Jan Raaijmakers
- Asthma symptoms in pediatric patients: Differences throughout the seasonsBy Ellen Koster, Jan Raaijmakers, Susanne Vijverberg and Anke-Hilse Maitland-van der ZeeEllen KosterPharmacoepidemiology & Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Utrecht, NetherlandsJan RaaijmakersPharmacoepidemiology & Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Utrecht, NetherlandsSusanne VijverbergPharmacoepidemiology & Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Utrecht, NetherlandsAnke-Hilse Maitland-van der ZeePharmacoepidemiology & Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Utrecht, Netherlands
- Factors associated with high levels of exhaled NO in children using asthma medicationBy Susanne Vijverberg, Ellen Koster, Leo Koenderman, Dirkje Postma, Gerard Koppelman, Kors van der Ent, Jan Raaijmakers and Anke-Hilse Maitland-van der ZeeSusanne VijverbergEllen Koster1UIPS, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, NetherlandsLeo Koenderman2Department of Respiratory Medicine, University Medical Center Utrecht, Utrecht, NetherlandsDirkje Postma3Department of Pulmonology, University Medical Center Groningen, University of Groningen, Groningen, NetherlandsGerard Koppelman4Department of Pediatric Pulmonology and Pediatric Allergology, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, NetherlandsKors van der Ent5Department of Pediatric Respiratory Medicine, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, NetherlandsJan Raaijmakers1UIPS, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, NetherlandsAnke-Hilse Maitland-van der Zee1UIPS, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, Netherlands
- Low agreement between current and long-term asthma control in children: The PACMAN cohort studyBy Ellen Koster, Jan Raaijmakers, Susanne Vijverberg, Leo Koenderman, Dirkje Postma, Gerard Koppelman, Cornelis van der Ent and Anke-Hilse Maitland-van der ZeeEllen Koster1Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, NetherlandsJan Raaijmakers1Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, NetherlandsSusanne Vijverberg1Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, NetherlandsLeo Koenderman2Pulmonary Diseases, University Medical Center Utrecht, Utrecht, NetherlandsDirkje Postma3Pulmonology, University Medical Center Groningen, Groningen, NetherlandsGerard Koppelman4Pediatric Pulmonology and Pediatric Allergology, University Medical Center Groningen, Groningen, NetherlandsCornelis van der Ent5Pediatric Pulmonology, University Medical Center Utrecht, Utrecht, NetherlandsAnke-Hilse Maitland-van der Zee1Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, Netherlands
- LSC 2013 abstract - ST13 and ORMDL3 polymorphisms affect the risk of exacerbations in steroid-treated asthmatic children and young adultsBy Susanne Vijverberg, Ellen Koster, Roger Tavendale, Maarten Leusink, Leo Koenderman, Jan Raaijmakers, Dirkje Postma, Gerard Koppelman, Steve Turner, Somnath Mukhopadhyay, Sze Man Tse, Kelan Tantisira, Colin Palmer and Anke-Hilse Maitland-van der ZeeSusanne Vijverberg1Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, Utrecht, Netherlands3Department of Respiratory Medicine, University Medical Centre Utrecht, Utrecht, NetherlandsEllen Koster1Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, Utrecht, NetherlandsRoger Tavendale2Population Pharmacogenetics Group, Biomedical Research Institute, University of Dundee, Ninewells Hospital and Medical School, Dundee, United KingdomMaarten Leusink1Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, Utrecht, NetherlandsLeo Koenderman3Department of Respiratory Medicine, University Medical Centre Utrecht, Utrecht, NetherlandsJan Raaijmakers1Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, Utrecht, NetherlandsDirkje Postma4Department of Pulmonology, Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, NetherlandsGerard Koppelman5Department of Paediatric Pulmonology and Paediatric Allergology, Beatrix Children's Hospital, Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center, Groningen, NetherlandsSteve Turner6Department of Child Health, University of Aberdeen, Aberdeen, United KingdomSomnath Mukhopadhyay2Population Pharmacogenetics Group, Biomedical Research Institute, University of Dundee, Ninewells Hospital and Medical School, Dundee, United Kingdom8Department of Paediatrics, Royal Alexandra Children's Hospital, Brighton and Sussex Medical School, Brighton, United KingdomSze Man Tse7Department of Medicine, Brigham and Women's Hospital, Boston, United StatesKelan Tantisira7Department of Medicine, Brigham and Women's Hospital, Boston, United StatesColin Palmer2Population Pharmacogenetics Group, Biomedical Research Institute, University of Dundee, Ninewells Hospital and Medical School, Dundee, United KingdomAnke-Hilse Maitland-van der Zee1Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, Utrecht, Netherlands
- LSC 2013 abstract - ST13 and ORMDL3 polymorphisms affect the risk of exacerbations in steroid-treated asthmatic children and young adultsBy Susanne Vijverberg, Ellen Koster, Roger Tavendale, Maarten Leusink, Leo Koenderman, Jan Raaijmakers, Dirkje Postma, Gerard Koppelman, Steve Turner, Somnath Mukhopadhyay, Sze Man Tse, Kelan Tantisira, Colin Palmer and Anke-Hilse Maitland-van der ZeeSusanne Vijverberg1Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, Utrecht, Netherlands3Department of Respiratory Medicine, University Medical Centre Utrecht, Utrecht, NetherlandsEllen Koster1Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, Utrecht, NetherlandsRoger Tavendale2Population Pharmacogenetics Group, Biomedical Research Institute, University of Dundee, Ninewells Hospital and Medical School, Dundee, United KingdomMaarten Leusink1Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, Utrecht, NetherlandsLeo Koenderman3Department of Respiratory Medicine, University Medical Centre Utrecht, Utrecht, NetherlandsJan Raaijmakers1Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, Utrecht, NetherlandsDirkje Postma4Department of Pulmonology, Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, NetherlandsGerard Koppelman5Department of Paediatric Pulmonology and Paediatric Allergology, Beatrix Children's Hospital, Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center, Groningen, NetherlandsSteve Turner6Department of Child Health, University of Aberdeen, Aberdeen, United KingdomSomnath Mukhopadhyay2Population Pharmacogenetics Group, Biomedical Research Institute, University of Dundee, Ninewells Hospital and Medical School, Dundee, United Kingdom8Department of Paediatrics, Royal Alexandra Children's Hospital, Brighton and Sussex Medical School, Brighton, United KingdomSze Man Tse7Department of Medicine, Brigham and Women's Hospital, Boston, United StatesKelan Tantisira7Department of Medicine, Brigham and Women's Hospital, Boston, United StatesColin Palmer2Population Pharmacogenetics Group, Biomedical Research Institute, University of Dundee, Ninewells Hospital and Medical School, Dundee, United KingdomAnke-Hilse Maitland-van der Zee1Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, Utrecht, Netherlands
- Asthmatic children that are uncontrolled despite inhaled corticosteroids have a distinct breathprint: Results of the PACMAN2 studyBy Susanne Vijverberg, Paul Brinkman, Jan Raaijmakers, Kors Van der Ent, Peter Sterk, Anke-Hilse Maitland- van der Zee and Leo KoendermanSusanne Vijverberg1Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands2Respiratory Medicine, UMC Utrecht, Utrecht, NetherlandsPaul Brinkman3Respiratory Medicine, AMC, University of Amsterdam, Amsterdam, NetherlandsJan Raaijmakers1Pharmaceutical Sciences, Utrecht University, Utrecht, NetherlandsKors Van der Ent4Pediatric Respiratory Medicine, WKZ, UMC Utrecht, Utrecht, NetherlandsPeter Sterk3Respiratory Medicine, AMC, University of Amsterdam, Amsterdam, NetherlandsAnke-Hilse Maitland- van der Zee1Pharmaceutical Sciences, Utrecht University, Utrecht, NetherlandsLeo Koenderman2Respiratory Medicine, UMC Utrecht, Utrecht, Netherlands
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.
